Medical Industry Feature
Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
31-45 of 106
Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Jennifer Caudle, DO, FACOFP
Gregory McMahon, DO
Potential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Medical Industry FeaturePotential for Early Intervention in 1L HR+/HER2- Advanced Breast Cancer
Seth Wander, MD, PhD
Retinal Perfusion, Sensitivity, and Function in DR
Medical Industry FeatureRetinal Perfusion, Sensitivity, and Function in DR
Barton Lynn Blackorby, MD
Katherine E. Talcott, MD
Hong-Uyen Hua, MD
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
- advertisement
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Charles Turck, PharmD, BCPS, BCCCP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Addressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Medical Industry FeatureAddressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Charles Turck, PharmD, BCPS, BCCCP
Matthew Brunner, MHS, PA-C
Douglas DiRuggiero, DMSc, PA-C
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Medical Industry FeatureOvercoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
- advertisement
Is It Time to Rethink How We Support Depression Management?
Medical Industry FeatureIs It Time to Rethink How We Support Depression Management?
Charles Turck, PharmD, BCPS, BCCCP
Andrew J. Cutler, MD
Gustavo Alva, MD, DFAPA
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
Depression from Case to Clinic: Rethinking Partial Response with a Different Approach
Medical Industry FeatureDepression from Case to Clinic: Rethinking Partial Response with a Different Approach
Ashley Baker, MSN, PMHNP
Kimberly Giberga, MSN, APRN, FNP-C, PMHNP-BC
Bradford Perkins, MD
